Related Experiment Video
Updated: Feb 9, 2026

Activating Autophagy by Aerobic Exercise in Mice
Published on: February 3, 2017
mTORC1/2 inhibitor and curcumin induce apoptosis through lysosomal membrane permeabilization-mediated autophagy
Seung Un Seo1, Seon Min Woo1, Hyun-Shik Lee2
1Department of Immunology, School of Medicine, Keimyung University, 2800 Dalgubeoldaero, Dalseo-Gu, Daegu, 704-701, South Korea.
Abstract:
mTOR is an important regulator of cell growth and forms two complexes, mTORC1/2. In cancer, mTOR signaling is highly activated, and the regulation of this signaling, as an anti-cancer strategy, has been emphasized. However, PP242 (inhibitor of mTORC1 and mTORC2) alone did not induce human renal carcinoma cell death. In this study, we found that PP242 alone did not alter cell viability, but combined curcumin and PP242 treatment induced cell death. Combined PP242 and curcumin treatment induced Bax activation and decreased expression of Mcl-1 and Bcl-2. Furthermore, co-treatment with PP242 and curcumin-induced the downregulation of the Rictor (an mTORC2 complex protein) and Akt protein levels, and ectopic overexpression of Rictor or Akt inhibited PP242 plus curcumin induced cell death. Downregulation of Rictor increased cytosolic Ca2+ release from endoplasmic reticulum, which led to lysosomal damage in PP242 plus curcumin-treated cells. Furthermore, damaged lysosomes induced autophagy. Autophagy inhibitors markedly inhibited cell death. Finally, combined curcumin and PP242 treatment reduced tumor growth and induced cell death in xenograft models. Altogether, our results reveal that combined PP242 and curcumin treatment could induce autophagy-mediated cell death by reducing the expression of Rictor and Akt in renal carcinoma cells.
Insights
Combining PP242 and curcumin induces cancer cell death by activating autophagy. This novel strategy targets Rictor and Akt, offering a promising approach for renal carcinoma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- Mammalian target of rapamycin (mTOR) signaling is crucial for cell growth and dysregulated in cancer.
- mTOR forms complexes mTORC1 and mTORC2, both implicated in cancer progression.
- Targeting mTOR signaling is a key anti-cancer strategy, but single-agent efficacy varies.
Purpose of the Study:
- To investigate the efficacy of combining PP242, an mTOR inhibitor, with curcumin in treating human renal carcinoma.
- To elucidate the molecular mechanisms underlying PP242 and curcumin-induced cell death.
- To evaluate the therapeutic potential of this combination in preclinical cancer models.
Main Methods:
- Human renal carcinoma cells were treated with PP242 alone or in combination with curcumin.
- Cell viability, apoptosis markers (Bax, Mcl-1, Bcl-2), protein levels (Rictor, Akt), cytosolic Ca2+ release, lysosomal integrity, and autophagy were assessed.
- Overexpression of Rictor or Akt was used to confirm their roles.
- Tumor growth was evaluated in xenograft models.
Main Results:
- PP242 alone did not affect cell viability, but the combination with curcumin induced significant cell death.
- Combined treatment activated Bax, decreased Mcl-1 and Bcl-2 expression, and downregulated Rictor and Akt.
- Rictor downregulation led to increased cytosolic Ca2+ release, lysosomal damage, and subsequent autophagy.
- Overexpressing Rictor or Akt attenuated PP242 plus curcumin-induced cell death.
- Autophagy inhibition markedly reduced cell death.
- Combination treatment reduced tumor growth in xenograft models.
Conclusions:
- Combined PP242 and curcumin treatment effectively induces autophagy-mediated cell death in renal carcinoma.
- The mechanism involves downregulation of Rictor and Akt, leading to lysosomal damage and autophagy.
- This combination therapy shows promise for renal carcinoma treatment by targeting key survival pathways and inducing cell death via autophagy.
Related Concept Videos
Lysosomes
Apoptosis
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Lysosomal Hydrolases
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

